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Abstract
Background. Co-occurrence of common mental disorders (CMD) with psychotic experiences
is well-known. There is little research on the public mental health relevance of concurrent
psychotic experiences for service use, suicidality, and poor physical health. We aim to: (1)
describe the distribution of psychotic experiences co-occurring with a range of non-psychotic
psychiatric disorders [CMD, depressive episode, anxiety disorder, probable post-traumatic
stress disorder (PTSD), and personality dysfunction], and (2) examine associations of concur-
rent psychotic experiences with secondary mental healthcare use, psychological treatment use
for CMD, lifetime suicide attempts, and poor self-rated health.
Methods. We linked a prospective cross-sectional community health survey with a mental
healthcare provider database. For each non-psychotic psychiatric disorder, patients with con-
current psychotic experiences were compared to those without psychotic experiences on use of
secondary mental healthcare, psychological treatment for CMD, suicide attempt, physical
functioning, and a composite multimorbidity score, using logistic regression and Cox
regressions.
Results. In all disorders except for anxiety disorder, concurrent psychotic experiences were
accompanied by a greater odds of all outcomes (odds ratios) for a unit change in composite
multimorbidity score ranged between 2.21 [95% confidence interval (CI) 1.49–3.27] and 3.46
(95% CI 1.52–7.85). Hazard ratios for secondary mental health service use for non-psychotic
disorders with concurrent psychotic experiences, ranged from 0.53 (95% CI 0.15–1.86) for
anxiety disorders with psychotic experiences to 4.99 (95% CI 1.22–20.44) among those
with PTSD with psychotic experiences.
Conclusions. Co-occurring psychotic experiences indicate greater public mental health bur-
den, suggesting psychotic experiences could be a marker for future preventive strategies
improving public mental health.
Introduction
Self-reported psychotic experiences such as hearing voices, experiencing paranoid thoughts,
are common in the general population. These experiences have been conceptualised as existing
on a continuum with psychotic illness (Linscott and van Os, 2013), although this has been
challenged (Parnas and Henriksen, 2016). Psychotic experiences are distinct from clinically
detectable attenuated psychotic symptoms reported by help-seeking individuals (Fusar-Poli
et al., 2016). Self-reported psychotic experiences in non-psychotic psychiatric disorders
could be an indicator of greater illness severity or poorer healthcare outcomes compared
with experiencing the same disorders without psychotic experiences. Nonetheless, although
there exists a large literature on general population co-occurrence of psychotic experiences
with other psychiatric disorders, including depression (Koyanagi et al., 2016), anxiety
(Kelleher et al., 2014), post-traumatic stress disorder (PTSD) (Kilcommons et al., 2008),
and personality disorders (Newton-Howes et al., 2008), there has been more limited examin-
ation of the implications of this comorbidity for public mental health. In particular,
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co-occurrence of psychotic experiences with non-psychotic psy-
chiatric disorders could indicate greater psychopathological symp-
tom burden, worse overall prognosis in terms of later use of
health services, worse longer term functioning, or specific impli-
cations for physical health (Sharifi et al., 2015; Scott et al., 2018;
Oh et al., 2019), or suicide (Kelleher et al., 2012). People with
psychotic experiences present more frequently to specialist mental
health services than the general population (Kobayashi et al.,
2011; Murphy et al., 2012; DeVylder et al., 2014b), however infor-
mation on use of psychological treatment for common mental
disorders (CMDs) is more limited (Perez et al., 2018).
Psychiatric symptoms reported in general population surveys
are also associated with worse physical health and functioning
(Phelan et al., 2001; Moreno et al., 2013) and health-related qual-
ity of life (Alonso et al., 2018). However, although the possible
relevance of psychotic experiences for physical health has been
examined in large-scale epidemiological data (Saha et al., 2011;
Moreno et al., 2013), the effect of psychotic experiences concur-
rent with non-psychotic psychiatric disorders on physical func-
tioning has received a limited amount of attention.
We therefore aim (1) to describe the distribution of self-
reported psychotic experiences co-occurring with a range of non-
psychotic psychiatric disorders, and (2) to examine the association
of these comorbid psychotic experiences with outcomes of public
health importance: use of secondary mental healthcare, use of
psychological treatment for CMDs, lifetime suicide attempts,
and poor self-rated health.
Methods
Sample details
This study linked a cross-sectional community health survey with
a mental healthcare provider database. The South East London
Community Health Study, SELCoH (Hatch et al., 2011), is a rep-
resentative household survey whose first wave (SELCoH-1) took
place in 2008–2010. The survey used random household sampling
to identify a representative sample of adults aged 16–90 years liv-
ing in Lambeth and Southwark. Sampling was clustered by house-
hold, with all adults living in selected households invited to
participate. Full details of the study, its sampling methods, and
representativeness are described elsewhere (Hatch et al., 2011).
Among 1698 participants surveyed, 86% gave permission for link-
age to specialist mental health records, where those records were
available. Data on participants were linked to electronic health
record data on use of mental health services both before and
after SELCoH-1 interview (described further in the ‘Outcomes’
section). Data from SELCoH phase 2, a survey performed in
2012–2013 and based on the same sample, were used to ascertain
which participants had subsequently left the catchment area or
died (Hatch et al., 2016).
Measurements
Psychotic experiences
The Psychosis Screening Questionnaire (PSQ) (Bebbington and
Nayani, 1995) was used to assess psychotic experiences. This is
a five-item self-report questionnaire which evaluates different
psychotic experiences domains experienced in the previous year.
These comprise: hypomania, strange experiences, paranoia, hallu-
cinations, and thought disorder. Each domain contains an initial
‘probe’ item followed by secondary questions. Because the current
study was focused on common psychiatric disorders co-occurring
with non-affective psychotic experiences, responses to the hypo-
mania item were not examined. Individuals were considered to
have psychotic experiences if they endorsed one or more second-
ary items in the four remaining domains. The PSQ displays good
correspondence with psychosis items on the Schedules for
Clinical Assessment in Neuropsychiatry (Bebbington and
Nayani, 1995), and has seen frequent use in population studies
(Bebbington et al., 2004).
Non-psychotic psychiatric disorders
CMDs were assessed by the Revised Clinical Interview Schedule
(CIS-R) (Lewis et al., 1992), giving a score out of 49 for symptoms
occurring within the previous 4 weeks. In line with previous stud-
ies (Hatch et al., 2016), we categorised scores into groups for
scores of 0–11 (no CMD), 12–18 (mild/moderate symptoms of
CMD), and over 18 (severe symptoms of CMD). Diagnoses of
depressive episode and anxiety disorder were derived through a
standard ICD-10 based algorithm. The anxiety disorder category
included those with derived diagnoses of generalised anxiety dis-
order, obsessive-compulsive disorder, mixed anxiety and depres-
sion, specific phobia, social phobia, agoraphobia, generalised
anxiety disorder, and panic disorder. Post-traumatic stress symp-
toms in the past month were assessed using the PC-PTSD (Prins
et al., 2003), a screening tool for PTSD designed for primary care
use, which is based on the diagnostic criteria for PTSD in DSM-V.
We used a cut-off point of 3 or more to define probable PTSD,
which has been shown to have high specificity (0.88) and accept-
able sensitivity (0.76) (Cameron and Gusman, 2003). Personality
dysfunction (PD) was assessed using the Standardised Assessment
of Personality-Abbreviated Scale (SAPAS), a rapid screen for per-
sonality disorder, which has demonstrated good psychometric
properties (Moran et al., 2003) and clinical utility (Bock et al.,
2010; Bukh et al., 2010; Germans et al., 2012). The SAPAS con-
sists of eight questions, corresponding to descriptive statements
about the person’s usual behaviour, currently. Binary responses
are summed to derive an overall score, for which a cut-off of 4
was used, which has showed satisfactory positive predictive
value in community settings (Moran et al., 2003).
Covariates
SELCoH-1 collected sociodemographic, environmental and health
information. Ethnicity was operationalised as a five-category vari-
able comprising white, black African, black Caribbean, Asian, and
other groups. Marital status was categorised into single, married/
cohabiting, divorced/separated, and widowed. Drug use informa-
tion was ascertained by self-report of use of any illicit drug (can-
nabis, crack, cocaine, ecstasy, LSD, and heroin) in the previous
year. Alcohol use patterns in the past year were measured using
the AUDIT scale (Saunders et al., 1993), using a cut-off of 8 to
identify hazardous alcohol use, in line with previous studies.
Outcomes
Two indicators of mental health service use were used: specialist
mental health service use, and use of psychological treatment
for CMDs. Specialist mental health service use was ascertained
using data from the National Institute of Health Research
Biomedical Research Centre at the Maudsley’s Clinical Record
Interactive Search (CRIS) (Stewart et al., 2009) system. The
South London and Maudsley NHS Foundation Trust (SLaM) is
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the sole provider of public mental healthcare in the two boroughs
of South London that were surveyed in SELCoH-1, covering a
catchment population of approximately 620 000. The Trust has
used a single electronic health record across all clinical services
known as the electronic Patient Journey System (ePJS) since
2006. The CRIS system extracts de-identified clinical data from
ePJS including structured fields for ICD-10 diagnoses, treatments
and admissions to hospital. The Improving Access to
Psychological Treatment (IAPT) programme is a national net-
work of services providing psychological treatment for CMDs,
spanning primary and secondary care. For this study, linkage of
SELCoH-1 data was also carried out to IAPT-CRIS, an electronic
system extracting de-identified clinical data from IAPTUS, the
electronic system used by professionals providing IAPT-based
treatment, which includes structured fields for ICD-10 diagnoses,
treatments, and outcome.
Linkage of SELCoH-1 to CRIS and IAPT-CRIS was carried out
by an independent Clinical Data Linkage Service (CDLS), and
used personal identifiers (name, date of birth, NHS number, post-
code, and gender) to probabilistically link survey data with match-
ing electronic health records (Centre, 2015). Data on SELCoH-1
participants who had consented to record linkage were then scru-
tinised in CRIS and IAPT-CRIS for date of referral. This linked
information was used to derive two binary variables for any spe-
cialist mental health service use (from CRIS), and any use of psy-
chological treatment (from IAPT-CRIS), and two variables for
survival analysis, for time to contact with specialist mental health
services (from CRIS), and time to use of psychological treatment
(from IAPT-CRIS). Referral information for this study was avail-
able from 1st April 1999 to 15th May 2017 for specialist mental
health service use, and from 1st January 2008 until 31st
November 2018 for use of psychological treatment.
Physical functioning was measured in SELCOH-1 using the
physical component of the SF-12 (Ware and Kosinski, 2001), a
12 item scale capturing limitation in daily activities for physical
health reasons in the previous 4 weeks. Poor physical functioning
was a binary indicator based on the lowest quartile of the physical
component score on the SF-12 (Das-Munshi et al., 2008). Finally,
lifetime suicide attempt was evaluated using a self-report item in
SELCoH-1.
Ethical approval
The SELCoH-1 study received approval from the King’s College
London research ethics committee, reference CREC/07/08-152.
The CRIS data resource received ethical approval as an anon-
ymised data set for secondary analyses from Oxfordshire REC
C, reference 08/H0606/71+5.
Comorbidity
Non-psychotic psychiatric disorders were defined by dichotomis-
ing scales as described above. For each possible combination of
psychotic experiences and non-psychotic psychiatric disorder, a
four-level categorical variable was created, reflecting those with
neither psychotic experiences nor disorder, disorder without
psychotic experiences, psychotic experiences without disorder,
and psychotic experiences and disorder. For example, the
PTSD-psychotic experiences comorbidity variable had the follow-
ing levels: (a) neither psychotic experiences nor PTSD, (b) PTSD
only, (c) psychotic experiences only, and (d) both psychotic
experiences and PTSD.
Analyses
All analyses were carried out in STATA 14 (StataCorp, 2014), and
took account of survey design, household clustering, and non-
response within households. Frequencies and prevalence of
psychotic experiences were described within each non-psychotic
psychiatric disorder, outcome, and all covariates. Frequencies
and prevalence of each outcome were described for participants
with each non-psychotic psychiatric disorder and concurrent
psychotic experiences.
Binary outcomes for logistic regression modelling were: spe-
cialist mental health service use, use of psychological treatment,
lifetime history of suicide attempt, and lowest-quartile of the
SF-12 physical component score.
Logistic regressions were estimated for each pairing of non-
psychotic psychiatric disorder and outcome. For each non-
psychotic psychiatric disorder, we estimated odds ratios (ORs)
for the association between that disorder and the outcome, the
association of psychotic experiences with the outcome, and the
additive interaction between the two, calculating the interaction
contrast ratio (ICR, also referred to as the relative excess risk
due to interaction) describing the extent of departure of the rela-
tionship between psychotic experiences and each non-psychotic
psychiatric disorder from an additive relationship, and a likeli-
hood ratio test to assess statistical evidence for departure of the
relationship from additivity (a small p value indicating evidence
of interaction). All models included age as continuous variable,
gender, and ethnicity as a priori confounders. Marital status,
drug use, and hazardous alcohol use were evaluated as potential
confounders, and not included models as adjusted estimates did
not change by greater 10% of the crude value, on inclusion of
any of these variables (Greenland et al., 2016). Based on this
approach, final models were adjusted for age, gender, and ethnic
group.
Survival analysis
We also took information on all referrals to specialist mental
health services, and to psychological treatment for CMDs occur-
ring subsequently to the survey interview (Bhavsar et al., 2017), in
order to test the association between experiencing non-psychotic
psychiatric disorder with concurrent psychotic experiences and
time to specialist mental health service use, and time to use of
psychological treatment. After assessing proportionality of
hazards with a statistical test based on Schoenfeld residuals,
survey-weighted Cox regression analyses were conducted, evaluat-
ing the association of concurrent psychotic experiences on time to
secondary mental healthcare use, adjusting for age, gender, and
ethnic group. As for logistic regressions described, we estimated
ICRs and likelihood ratio tests for interaction on the additive
scale.
Results
Psychotic experiences were reported by 19.7% of the study popu-
lation. Table 1 shows the socio-demographic and clinical associa-
tions of psychotic experiences. Psychotic experiences were less
frequently reported in older participants, similarly distributed
by sex, but more frequently reported by those who identified as
black Caribbean or black African than other ethnic groups.
Psychotic experiences were most common among single people,
and least common among married/cohabiting respondents.
Psychological Medicine 3
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There was a noticeably higher prevalence of psychotic experiences
with increasing symptoms. Similarly, psychotic experiences were
reported more frequently in those experiencing every non-
psychotic psychiatric disorder that was included in this study.
Psychotic experiences were reported around a quarter of those
with any use of psychological treatment for CMDs (25.4%), and
nearly two-fifths of those with specialist mental health service
use (38.1%), and 34.3% of those with relatively poor physical
functioning. More than two-fifths of those reporting a lifetime
history of suicide attempts (42.7%) reported psychotic
experiences.
Table 2 describes, for each non-psychotic psychiatric disorder,
how the concurrent presence of psychotic experiences was asso-
ciated with specialist mental health service use, use of psycho-
logical treatment, lifetime suicide attempt, and poor physical
functioning. With the exception of the association of anxiety dis-
order with use of psychological treatment, all outcomes were
more common in those with non-psychotic psychiatric disorders
with concurrent psychotic experiences compared to those with-
out. Among participants reporting psychiatric disorders with con-
current psychotic experiences, proportions with specialist mental
health service use ranged from 14% among those reporting mild/
moderate symptoms of CMD with psychotic experiences, to
57.6% among those reporting PTSD with psychotic experiences.
Table 1. Non-psychotic psychiatric disorders, sociodemographic characteristics
and outcomes by psychotic experiences (PE) status
Overall n in
category
Number with
PE (%)
Age
16–24 300 78 (25.8)
25–34 316 55 (17.9)
35–44 293 54 (18.4)
45–54 223 53 (24.0)
55–64 138 19 (13.8)
65+ 146 15 (10.4)
Gender
Male 615 126 (20.8)
Female 801 148 (18.7)
Ethnic group
White 917 154 (17.2)
Black Caribbean 112 33 (29.1)
Black African 178 43 (24.4)
Asian 47 8 (16.3)
Other 162 36 (22.6)
Marital status
Single 550 135 (24.8)
Married/cohabit 668 91 (13.7)
Divorced/separate 155 42 (27.4)
Widowed 43 6 (14.4)
Unemployment
No 1272 225 (18.0)
Yes 139 139 (34.2)
Hazardous alcohol usea
No 1117 199 (18.1)
Yes 298 75 (25.3)
Recent drug useb
No 1101 183 (16.9)
Yes 315 91 (28.7)
CMD symptomsc
No 1077 136 (13.0)
Mild/moderate 169 55 (33.5)
Severe 170 83 (49.2)
Depressive episoded
No 1253 207 (17.0)
Yes 163 67 (41.1)
Anxiety disorderd
No 1286 228 (18.0)
Yes 130 46 (36.1)
PTSDe
No 1344 239 (18.1)
Yes 72 35 (50.1)
(Continued )
Table 1. (Continued.)
Overall n in
category
Number with
PE (%)
PDf
No 1218 195 (16.4)
Yes 198 79 (40.4)
Secondary mental health
service useg
No 1231 205 (17.0)
Yes 185 69 (38.1)
Use of psychological
treatment servicesg
No 1227 227 (18.8)
Yes 189 47 (25.4)
Lifetime suicide attempt
No 1307 228 (17.5)
Yes 109 46 (42.7)
Poor physical functioningh
No 1162 188 (16.7)
Yes 254 86 (34.3)
Overall sample 1416 274 (19.7)
Percentages are weighted for survey design and non-response within households.
aDefined as scoring 8 or above on the AUDIT.
bUse of any of the following in the previous year: cannabis, cocaine, crack, opiates,
amphetamines, ecstasy, and LSD.
cBased on scores on the Clinical Interview Schedule-Revised (CIS-R).
dDerived from items on the CIS-R.
eDerived from the PC-PTSD with a cut-off of 3.
fDerived from the SAPAS.
gBased on linkage to databases for specialist mental health records including secondary
mental health services and use of psychological treatment services.
hBinary indicator based on the lowest quartile of the physical component score on the
SF-12.
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Use of psychological treatment among those with psychiatric dis-
orders concurrent with psychotic experiences ranged from 11.7%
among those with mild/moderate symptoms of CMD and psych-
otic experiences to 41.9% among those with PTSD and psychotic
experiences. The proportion reporting lifetime suicide attempt
among those with concurrent psychiatric disorders with psychotic
experiences ranged from 17.6% among those reporting mild/mod-
erate symptoms of CMD with psychotic experiences, to 42.8% in
those with PTSD with psychotic experiences. The proportion of
those experiencing poor physical functioning ranged from
29.6% of those with mild/moderate symptoms of CMD with
psychotic experiences to 67.4% of those with depressive episode
and psychotic experiences.
Table 3 displays adjusted associations of each non-psychotic
psychiatric disorder with specialist mental health service use,
use of psychological treatment, lifetime suicide attempt and
poor physical functioning. All comparisons are made to the
group without psychotic experiences and each non-psychotic psy-
chiatric disorder. The associations of concurrent psychotic experi-
ences with secondary mental health service use ranged from ORs
Table 2. Frequencies and proportions for analysed outcomes for each PE-comorbidity
N in
category
Secondary mental health
service usea
Use of psychological
treatment servicesa
Lifetime suicide
attempt
Poor physical
functioningb
CMD symptomsc
Neither 941 74 (7.5) 92 (9.5) 35 (3.6) 84 (8.3)
PE and no CMD 136 23 (16.8) 19 (14.1) 10 (7.3) 14 (9.5)
No PE and mild/
moderate CMD
114 24 (20.6) 27 (23.6) 14 (11.7) 42 (35.7)
PE and mild/
moderate CMD
55 8 (14.0) 7 (11.7) 10 (17.6) 17 (29.6)
No PE and severe
CMD
87 18 (21.0) 23 (26.1) 14 (15.9) 42 (47.5)
PE and severe CMD 83 38 (45.6) 21 (25.3) 26 (31.0) 55 (64.5)
Depressive episoded
Neither 1046 95 (8.8) 119 (11.1) 48 (4.4) 127 (11.4)
Depressive episode
only
96 21 (21.4) 23 (23.2) 15 (15.5) 41 (41.3)
PE only 207 39 (18.3) 29 (13.9) 25 (11.8) 40 (18.0)
Depressive episode
with PE
67 30 (45.1) 18 (26.7) 21 (31.1) 46 (67.4)
Anxiety disorderd
Neither 1058 99 (9.0) 123 (11.3) 57 (5.2) 144 (12.8)
Anxiety disorder only 84 17 (20.1) 19 (22.7) 6 (6.8) 24 (28.3)
PE only 228 55 (23.7) 39 (16.8) 36 (15.3) 67 (27.7)
Anxiety disorder with
PE
46 14 (29.4) 8 (17.2) 10 (21.2) 19 (38.8)
PTSDe
Neither 1105 107 (9.4) 133 (11.8) 56 (4.9) 151 (12.9)
PTSD only 37 9 (23.7) 9 (24.0) 7 (18.2) 17 (44.9)
PE only 239 49 (19.9) 32 (13.3) 31 (12.5) 62 (24.1)
PTSD with PE 35 20 (57.6) 15 (41.9) 15 (42.8) 24 (67.3)
PDf
Neither 1023 90 (8.4) 115 (10.9) 42 (3.9) 130 (12.0)
PD only 119 26 (21.7) 27 (23.3) 21 (17.0) 38 (30.1)
PE only 195 39 (19.5) 28 (14.3) 24 (11.8) 48 (23.1)
PD with PE 79 30 (37.6) 19 (23.4) 22 (27.5) 38 (46.1)
aBased on linkage to databases for specialist mental health records including secondary mental health services and use of psychological treatment services.
bBinary indicator based on the lowest quartile of the physical component score on the SF-12.
cBased on scores on the Clinical Interview Schedule-Revised (CIS-R).
dDerived from items on the CIS-R.
eDerived from the PC-PTSD with a cut-off of 3.
fDerived from the SAPAS.
Psychological Medicine 5
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Table 3. Estimates for the association (ORs and 95% CIs) of psychotic experiences (PE) concurrent with other mental disorders on public mental health, estimated
from survey-weighted logistic regression models with additive interaction terms
Secondary mental health
service usea
Use of psychological
treatment servicesa
Lifetime suicide
attempt
Poor physical
functioning
PE with CMD symptomsb
No PE or CMD Reference Reference Reference Reference
PE and no CMD 2.92 (1.80–4.74) 1.80 (1.06–3.03) 2.33 (1.10–4.95) 1.78 (0.93–3.38)
No PE and mild/moderate CMD 2.97 (1.80–4.91) 2.70 (1.67–4.37) 3.26 (1.71–6.21) 7.70 (4.69–12.65)
PE and mild/moderate CMD 2.24 (1.04–4.83) 1.24 (0.56–2.73) 5.96 (2.69–13.19) 8.06 (4.13–15.72)
No PE and severe CMD 3.04 (1.62–5.70) 2.90 (1.72–4.89) 4.31 (2.07–8.98) 13.14 (7.67–22.52)
PE and severe CMD 11.04 (6.63–18.38) 3.05 (1.73–5.37) 13.19 (7.14–24.35) 32.95 (18.49–58.69)
ICRc for PE and mild/moderate CMD −2.65 (−5.24 to −0.07) −2.26 (−4.12 to −0.40) 1.37 (−3.47 to 6.21) −0.42 (−6.38 to 5.54)
ICR for PE and severe CMD 6.09 (0.53–11.64) −0.65 (−2.92 to 1.62) 7.55(−0.13 to 15.23) 19.02 (0.80–37.25)
LRT p value for interaction 0.0107 0.0532 0.6611 0.2023
PE with depressive episoded
No PE or depressive episode Reference Reference Reference Reference
Depressive episode only 2.52 (1.47–4.30) 2.14 (1.28–3.57) 3.36 (1.76–6.43) 6.36 (4.03–10.02)
PE only 2.73 (1.82–4.10) 1.43 (0.92–2.20) 3.22 (1.89–5.48) 2.57 (1.64–4.01)
PE with depressive episode 9.04 (5.23–15.63) 2.76 (1.54–4.97) 10.70 (5.62–20.37) 21.49 (11.63–39.73)
ICR for PE and depressive episode 4.79 (−0.15 to 9.73) 0.20 (−1.72 to 2.12) 5.12 (−1.47 to 11.71) 13.57 (0.77–26.36)
LRT p value for interaction 0.532 0.8032 0.9775 0.5479
PE with anxiety disorderd
No PE or anxiety episode Reference Reference Reference Reference
Anxiety disorder only 2.57 (1.42–4.64) 2.12 (1.22–3.68) 1.22 (0.51–2.92) 3.39 (1.87–6.15)
PE only 3.68 (2.56–5.29) 1.72 (1.16–2.57) 3.72 (2.29–6.03) 3.84 (2.62–5.63)
PE with anxiety disorder 4.78 (2.53–9.04) 1.65 (0.75–3.62) 5.42 (2.50–11.77) 6.63 (3.40–12.94)
ICR for PE and anxiety disorder −0.47 (−3.85 to 2.92) −1.20 (−3.07 to 0.67) 1.48 (−2.81 to 5.78) 0.40 (−4.21 to 5.02)
LRT p value for interaction 0.1742 0.1284 0.7876 0.1794
PE with PTSDe
No PE or PTSD Reference Reference Reference Reference
PTSD only 2.58 (1.16–5.73) 1.90 (0.87–4.16) 3.35 (1.41–7.94) 5.35 (2.64–10.84)
PE only 2.73 (1.87–3.98) 1.27 (0.83–1.92) 3.05 (1.86–4.98) 3.14 (2.17–4.54)
PE with PTSD 15.95 (7.42–34.3) 5.46 (2.64–11.31) 17.83 (8.13–39.09) 23.54 (11.07–50.08)
ICR for PE and PTSD 11.65 (−0.52 to 23.81) 3.30 (−0.89 to 7.48) 12.44 (−1.26 to 26.13) 16.15 (−1.41,33.71)
LRT p value for interaction 0.1579 0.1242 0.4071 0.5043
PE with PD
No PE or PD Reference Ref Ref Ref
PD only 2.72 (1.62–4.60) 2.34 (1.45–3.79) 4.54 (2.48–8.31) 3.28 (2.10–5.14)
PE only 2.97 (1.96–4.49) 1.49 (0.96–2.33) 3.77 (2.16–6.59) 3.11 (2.03–4.75)
PE with PD 7.52 (4.41–12.80) 2.52 (1.44–4.42) 9.01 (4.86–16.68) 9.54 (5.71–15.94)
ICR for PE and PD 2.82 (−1.22 to 6.87) −0.32 (−2.13 to 1.50) 1.69 (−3.76 to 7.15) 4.15 (−0.54 to 8.84)
LRT p value for interaction 0.8981 0.569 0.137 0.8118
All estimates are adjusted for age, gender, and ethnic group.
aBased on linkage to databases for specialist mental health records including secondary mental health services and use of psychological treatment services.
bCMD symptoms based on categorisation of CIS-R score into three groups: 0–11 (no CMD), 12–18 (mild/moderate CMD), and over 18 (severe CMD).
cICR: interaction contrast ratio, quantifying interaction on the additive scale.
dDerived from items on the CIS-R.
eDerived from the PC-PTSD with a cut-off of 3.
fDerived from the SAPAS.
gBinary indicator based on the lowest quartile of the physical component score on the SF-12.
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of 2.24 [95% confidence interval (CI) 1.04–4.83] for mild/moder-
ate symptoms of CMD with psychotic experiences to 2.91(95% CI
1.37–6.19) for PD with psychotic experiences. Associations of
psychiatric disorders with psychotic experiences and psycho-
logical treatment ranged from an OR of 1.24 (95% CI 0.56–
2.73) in those with mild/moderate symptoms of CMD with
psychotic experiences to 5.46 (95% CI 2.64–11.31) in those with
psychotic experiences and PTSD. Associations with lifetime sui-
cide attempt ranged from an OR of 5.42 (95% CI 2.50–11.77)
among those with psychotic experiences with anxiety disorder
to 17.83 (95% CI 8.13–39.09) in those with psychotic experiences
with PTSD. Associations of concurrent psychotic experiences
with poor physical functioning ranged from an OR of 6.63
(95% CI 3.40–12.94) for psychotic experiences with anxiety dis-
order to 23.54 (95% CI 11.07–50.08) for psychotic experiences
with PTSD. Statistical evidence for interaction was found ( p =
0.01) between psychotic experiences and CMD on specialist men-
tal health service use with negative interaction between psychotic
experiences and mild/moderate CMD (ICR: −2.65, 95% CI −5.24
to −0.07), and positive interaction between psychotic experiences
and severe CMD (ICR: 6.09, 95% CI 0.53–11.64). Interaction
between psychotic experiences and CMD displayed a similar pat-
tern for use of psychological treatment, however there was insuf-
ficient statistical evidence of interaction ( p = 0.0532). There was
evidence of generally positive interaction on the additive scale
between psychotic experiences and CMD for both lifetime suicide
attempts and poor physical functioning. ICR point estimates sug-
gested positive interaction for psychotic experiences with depres-
sive episode for all outcomes, although statistical evidence was
insufficient. We found indication of negative interaction between
psychotic experiences and anxiety disorder on specialist mental
health service use, and on use of psychological treatment, but
not for lifetime suicide attempts and poor physical functioning.
Large ICRs were observed for the interaction between psychotic
experiences and PTSD for all outcomes, although all p values
were greater than 0.05.
Table 4 shows the results of survival analysis of the association
between non-psychotic psychiatric disorders with concurrent
psychotic experiences and subsequent use of specialist mental
health services, based on additive interaction terms. Compared
to those without those symptoms, statistical associations were
found for psychotic experiences concurrent with severe CMD
and with depressive episode, PTSD, and PD, but not for mild/
moderate CMD, or anxiety disorder. Estimates indicated a nearly
four-fold increase in the rate of mental health service use for con-
current psychotic experiences with PTSD compared to those
without psychotic symptoms or PTSD [hazard ratio (HR) 3.81,
95% CI 2.11–6.87], a 2.5-fold such increase in those with psych-
otic experiences concurrent with severe CMD (compared to those
with neither symptoms of CMD nor psychotic experiences, HR
2.59, 95% CI 1.52–4.40), more than a two-fold increase in those
with depressive episode concurrent with psychotic experiences
(HR 2.29, 95% CI 1.33–3.94) compared to those without psych-
otic experiences or depressive episode, and a nearly two-fold
such increase in those with psychotic experiences concurrent
with PD (compared to those without psychotic experiences or
PD, HR 1.03, 3.24).
Compared to those without those symptoms, statistical asso-
ciations with time to use of psychological treatment were found
for psychotic experiences concurrent with severe symptoms of
CMD, depressive episode, PTSD, and PD. Estimates indicated a
nearly three-fold increase in the rate of use of psychological
treatment among those reporting PD with psychotic experiences,
compared to those without these symptoms (HR 2.88, 95% CI
1.11–7.43), a nearly seven-fold increase in those reporting
PTSD with psychotic experiences compared to those without
(HR 6.80, 95% CI 3.18–14.54), a nearly six-fold increase among
those reporting psychotic experiences concurrent with depressive
episode (HR 5.90, 95% CI 3.11–11.18), and a similar increase
among those reporting psychotic experiences concurrent with
severe symptoms of CMD (HR 6.30, 95% CI 3.43–1.59).
Inspection of ICR suggested statistical evidence of negative inter-
action on the additive scale between psychotic experiences and
anxiety disorder on use of psychological treatment (ICR: −3.17,
95% CI −6.35 to 0.01, p = 0.014).
Discussion
Summary of findings
Consistent with previous literature (Linscott and van Os, 2013),
this investigation of a representative urban community sample
found psychotic experiences to be common (19.7%), and strongly
associated with non-psychotic psychiatric disorders. We found
that for each non-psychotic disorder, the presence of psychotic
experiences greatly increased the odds of specialist mental health
service use, psychological treatment for CMDs, lifetime suicide
attempts, and impairment of physical functioning. In general,
ICRs suggested positive synergy between psychotic experiences
and non-psychotic psychiatric symptoms on public mental health
need, with the exception of mild/moderate CMD and anxiety
disorders.
The prevalence of psychotic experiences identified in this
study falls within the highest decile of the distribution of previous
prevalence reports based on meta-analysis (Linscott and van Os,
2013), and is considerably higher than the national prevalence
of psychotic experiences based on a national survey of psychiatric
morbidity carried out in 2007 (Koyanagi et al., 2015). This is con-
sistent with the greater prevalence of socioeconomic disadvantage,
adversity, and substance use in densely populated urban areas
compared to the rest of the population (Morgan et al., 2014).
Previous literature
Frequent comorbidity between psychotic experiences and other
psychopathology, including depression (Ohayon and Schatzberg,
2002), and anxiety (Wigman et al., 2012), has been established
in previous clinical and epidemiological studies. For example, in
an analysis of four American general population datasets
(DeVylder et al., 2014a), psychotic experiences were markers of
a greater number of psychiatric symptoms. A number of studies
have also found psychotic experiences to be associated with
adverse public health outcomes, including suicidal behaviours
(Bromet et al., 2017), functional impairment, and disability
(Kelleher et al., 2015; Navarro‐Mateu et al., 2017; Oh et al.,
2018). For example, in a non-representative sample of 212 adoles-
cents (Kelleher et al., 2015), meeting criteria for an Axis I psychi-
atric diagnosis and endorsing psychotic experiences was
associated with worse functioning compared to those with a diag-
nosis not endorsing psychotic experiences. Based on a cross-
national sample of nearly 200 000 adults, Koyanagi et al. (2016)
found greater functional impairments in those with coexisting
depressive episode and psychotic experiences, compared to
those with depressive episode alone. In contrast to our study,
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Table 4. Prospective associations (HRs) and 95% CIs, for PE concurrent with CMDs and the rate of psychological treatment and the rate of contact with mental
health services
HR for use of psychological
treatmentf (95% CI)
HR for use of secondary mental
health servicesf (95% CI)
PE with CMD symptomsa
No PE or CMD Reference Reference
PE only 1.65 (1.00–2.72) 1.63 (0.76–3.49)
No PE with mild/moderate CMD 2.49 (1.59–3.90) 3.23 (1.78–5.87)
PE and mild/moderate CMD 1.19 (0.51–2.75) 2.36 (0.84–6.62)
No PE with severe CMD 2.86 (1.79–4.56) 1.84 (0.79–4.33)
PE and severe CMD 2.59 (1.52–4.40) 6.30 (3.43–1.59)
ICR for PE and mild/moderate CMD −1.95 (−3.67 to −0.24) −1.50 (−4.70 to 1.70)
ICR for PE and severe CMD −0.93 (−2.83 to 0.98) 3.83 (−0.06 to 7.72)
LRT p value for interaction 0.0714 0.0861
PE with depressive episodeb
No PE or depressive episode Reference Reference
PE only 1.37 (0.90–2.08) 1.63 (0.90–2.96)
Depressive episode 2.33 (1.47–3.69) 1.73 (0.83–3.61)
PE with depressive episode 2.29 (1.33–3.94) 5.90 (3.11–11.18)
ICR −0.41 (−2.03–1.22) 3.54 (−0.24 to 7.32)
LRT p value for interaction 0.4002 0.1695
PE with anxiety disorderc
No PE or anxiety disorder Reference Reference
PE only 1.56 (1.07–2.27) 2.89 (1.76–4.75)
Anxiety disorder 1.85 (1.08–3.18) 3.06 (1.54–6.09)
PE with anxiety disorder 1.43 (0.67–3.06) 1.79 (0.58–5.50)
ICR −0.97 (−2.54 to 0.59) −3.17(−6.35 to 0.01)
LRT p value for interaction 0.1568 0.0153
PE with PTSDd
No PE or PTSD Reference Reference
PE only 1.19 (0.80–1.79) 1.88(1.12–3.16)
PTSD 1.86 (0.95–3.66) 1.24 (0.36–4.29)
PE with PTSD 3.81 (2.11–6.87) 6.80 (3.18–14.54)
ICR 1.75 (−0.78 to 4.29) 4.68 (−0.60 to 9.96)
LRT p value for interaction 0.2371 0.1526
PE with PDe
No PE or PD Reference Reference
PE only 1.54 (1.02–2.32) 2.27 (1.29–4.00)
PD 2.38 (1.52–3.72) 1.06 (0.82–1.37)
PE with PD 1.83 (1.03–3.24) 2.88 (1.11–7.43)
ICR −1.09 (−2.63 to 0.45) 0.55 (−2.57 to 3.67)
LRT p value for interaction 0.1253 0.6089
All estimates are adjusted for age, gender, and ethnic group.
aCMD symptoms based on categorisation of CIS-R score into three groups: 0–11 (no CMD), 12–18 (mild/moderate CMD), and over 18 (severe CMD).
bICR: interaction contrast ratio, quantifying interaction on the additive scale.
cDerived from items on the CIS-R.
dDerived from the PC-PTSD with a cut-off of 3.
eDerived from the SAPAS.
fBased on linkage to databases for specialist mental health records including secondary mental health services and use of psychological treatment services.
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they did not find association between reporting concurrent psych-
otic experiences and poor physical functioning.
However, few studies have examined the public mental health
impact of intersection between psychotic experiences and non-
psychotic psychiatric disorders, which is important based on the
frequent overlap of psychotic experiences with other psychopath-
ology. Kelleher et al. (2014) examined the prevalence of previous
suicide attempts among Irish adolescents with psychiatric symp-
toms, comparing those reporting psychotic experiences to those
not reporting psychotic experiences. Examining affective, behav-
ioural and anxiety disorders, suicide attempts were associated
with reporting concurrent psychotic experiences compared to
experiencing these disorders without psychotic experiences. This
study ascertained clinical diagnoses, in a relatively small group
of help-seeking adolescents. In the general population based
World Mental Health surveys, psychotic experiences were pro-
spectively associated with attempted suicide (Bromet et al.,
2017), but investigators did not aim to examine the effect of
psychotic experiences concurrent with other psychiatric symp-
toms or disorders on the outcome. In contrast to previous studies,
we examine the influence of a comprehensive range of psychiatric
disorders comorbid with psychotic experiences on outcomes of
broad public mental health importance.
Studies on risk factors for psychotic experiences have typically
adjusted for other psychopathology as potential confounding vari-
ables, that is, as common causes of both exposure and outcome,
rather than assessing their implications in combination. For
example, McGrath et al. (2017) examined the prospective rela-
tionship between traumatic experiences and psychotic experiences
in the World Mental Health Surveys, finding increasingly strong
associations between traumatic experiences, and increasing num-
ber of traumatic experiences, and subsequent psychotic experi-
ences, after adjusting for PTSD and a range of other psychiatric
disorders. By assessing additive interaction between psychotic
experiences and non-psychotic psychiatric disorders, we were
able to compare the association between symptom comorbidities
with psychotic experiences on public mental health outcomes,
giving an indication of the possible importance of psychotic
experiences in a clinical context with other, commonly occurring
psychiatric symptoms.
Limitations
We were able to assess the interaction between non-psychotic psy-
chiatric disorders with comorbid psychotic experiences for a
range of mental disorders (including temporally prospective spe-
cialist mental health service use and use of psychological treat-
ment), and good statistical evidence was found for our main
comparisons. Nevertheless, our inferences could have been
affected by chance – some association estimates were based on
small numbers of participants. Models were identically specified
for each outcome, aiding comparison. However, some confoun-
ders could have applied to certain outcomes more strongly than
others. We had no information on timings, frequency or intensity
of psychotic experiences. Measurement accuracy may have been
influenced by the simultaneous assessment of psychopathology
in the same survey assessment, e.g. depressed mood may have
influenced the accuracy of psychotic experiences assessment,
and vice versa. Confounding by unknown, unmeasured, or poorly
measured/misreported characteristics is possible. Responders to
health surveys tend to be healthier than the general population
(Keyes et al., 2018), and so the true prevalence of mental health
service use for comorbid psychotic experiences in the general
population may be greater than that estimated here, although
our analysis incorporated non-response weights which probably
limited bias in estimates. Given the cross-sectional ascertainment
of concurrent psychotic experiences, we were unable to identify or
examine the temporal direction of associations between psychotic
experiences and non-psychotic psychiatric disorders, although
bi-directional relationships between psychotic experiences and
other psychiatric disorders are evident in previous literature
(McGrath et al., 2016). We were also unable to analyse direction
of causal association between psychotic experiences and suicide
attempt, or impairment of physical functioning. Although our
characterisation of non-psychotic psychiatric disorders was not
based on clinical interviews, we were able to derive ICD-10 diag-
noses from the rating of psychiatric symptoms, based on accepted
algorithms.
Explanations
Our findings underline the importance of taking account of non-
psychotic psychopathology when assessing the impact of psych-
otic experiences on mental health (Bhavsar et al., 2018). The
influence of psychotic experiences on help-seeking behaviour
could be dependent on the other psychiatric symptoms that are
experienced. For example, it is possible that psychotic experiences
themselves are less severe in those with mild/moderate CMD
compared to those with severe CMD, or that psychotic experi-
ences raise the threshold at which individuals with mild/moderate
CMD or anxiety seek help for mental disorders.
Frequent overlap between psychotic experiences and non-
psychotic psychiatric disorders observed in the current study is
consistent with a general psychopathological factor underlying
psychiatric disorders, proposed by Caspi and supported by gen-
etic, neuroimaging, and psychometric evidence (Klaassen et al.,
2013; Caspi et al., 2014; Frangou, 2014). This continuity may
also account for the occurrence of mood dysregulation during
the development of psychosis, prior to onset of positive psychotic
symptoms (Mishara and Fusar-Poli, 2013). Our results support
the possibility that psychotic experiences are non-specific markers
of overall psychopathology, and indicate that psychotic experi-
ences may be a relevant predictor of greater symptom burden,
in line with current understanding of psychosis as a more burden-
some psychiatric disorder in its own right. Given the strong asso-
ciations of psychotic experiences concurrent with non-psychotic
psychiatric disorders with service use and suicide attempts mea-
sured in this study, it is possible that concurrent psychotic experi-
ences explain some of the public mental health need attributable
to common psychiatric disorders in the general population.
The presence of psychotic experiences in a clinical presenta-
tion may be a marker of greater subsequent mental health need
(Bhavsar et al., 2017), and our results indicate that this may
also be true in the context of co-occurring non-psychotic psychi-
atric symptoms. Psychotic experiences could identify a higher risk
group for population-based interventions to improve public men-
tal health. The design of services could reflect the importance of
psychotic experiences for the prognosis of CMDs, and symptoms
of CMDs for the prognosis of psychotic conditions. Psychotic
experiences could be a useful, relatively easy to measure indicator
of later mental health need, which could be incorporated into
prognostic tools for mental health service use at a population
level, to guide commissioning of future services.
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